Lansec 30 mg (Capsule (Enteric Coated))
Unit Price: ৳ 6.05 (5 x 10: ৳ 302.50)
Strip Price: ৳ 60.50
Medicine Details
Category | Details |
---|---|
Generic | Lansoprazole |
Company | Drug international ltd |
Also available as |
Indications
- Short term treatment of active duodenal ulcer
- Maintenance of healed duodenal ulcers
- Short term treatment of active benign gastric ulcers
- Short term treatment of active erosive esophagitis
- Maintenance of healing of erosive esophagitis
- Pathological hypersecretory conditions including Zollinger-Ellison Syndrome
- H. pylori eradication to reduce the risk of duodenal ulcer recurrence
Pharmacology
- Substituted benzimidazole
- PPI (Proton Pump Inhibitor)
- Blocks final step of acid secretion
- Inhibits H+/K+ ATPase enzyme system
- Inhibits both basal and stimulated acid
Dosage & Administration
- 30 mg daily in the morning for benign gastric ulcer for 8 weeks
- 30 mg daily in the morning for duodenal ulcer for 4 weeks; maintenance 15 mg
- 15-30 mg daily for NSAID-associated duodenal or gastric ulcer
- Initially 60 mg once daily for Zollinger-Ellison syndrome; daily doses of 120 mg or more given in two divided doses
- 30 mg daily in the morning for gastroesophageal reflux disease for 4 weeks; maintenance 15-30 mg daily
- 15-30 mg daily in the morning for acid-related dyspepsia for 2-4 weeks
Interaction
- Selective inhibitor of the cytochrome P-450 monooxygenase system
- Effect on hepatic clearance
- No clinically relevant interactions reported
- Uncertain effect on the oral combined contraceptive pill
- Likely reduction in gastric acid influencing bacterial colonization and vitamin B12 absorption
Contraindications
- Known hypersensitivity to any component of the formulation
Side Effects
- Possible induction of carcinoid tumors by profound acid suppression
- Rise in serum gastrin levels
- Long term treatment may accelerate the development of atrophic gastritis
- Dose dependent diarrhea with an incidence of about 4% at 30 mg per day
- Headache occurs in 2-3% of treated patients
Pregnancy & Lactation
- Should be avoided in pregnancy unless there are compelling reasons
Precautions & Warnings
- Gastric malignancy should be ruled out
- Hepatic impairment
- Pregnancy and lactation
Use in Special Populations
- Neonates: Not recommended
- Children: Minimum age in clinical trials was 13 years old
- Elderly: No increase in adverse drug reaction reported
Therapeutic Class
- Proton Pump Inhibitor
Storage Conditions
- Store at 25°C
Related Brands
- Ulan 30 mg (Capsule (Enteric Coated)) - union-pharmaceuticals-ltd
- Lansoprol 30 mg (Capsule (Enteric Coated)) - ziska-pharmaceuticals-ltd
- Lap 30 mg (Capsule (Enteric Coated)) - ambee-pharmaceuticals-ltd
- Zoton 30 mg (Capsule (Enteric Coated)) - general-pharmaceuticals-ltd
- Protolan 30 mg (Capsule (Enteric Coated)) - beximco-pharmaceuticals-ltd